Point72 Asset Management
PRME icon

Point72 Asset Management’s Prime Medicine PRME Stock Holding History

Point72 Asset Management’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.97M Buy
+533,553
New +$1.77M ﹤0.01% 2399
2026
Q1 		– Sell
-551,030
Closed -$1.91M – 4335
2025
Q4 		$1.91M Buy
+551,030
New +$2.45M ﹤0.01% 2502
2025
Q1 		– Sell
-68,528
Closed -$200K – 2439
2024
Q4 		$200K Buy
+68,528
New +$241K ﹤0.01% 1882

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Point72 Asset Management's PRME Position: Q2 2026 in Review

Point72 Asset Management opened a new position in Prime Medicine (PRME) in Q2 2026: 533,553 shares worth $1.97M. The stake represents ﹤0.01% of the portfolio and ranks #2399 among its holdings. This is a return to the name: Point72 Asset Management previously reported a position in PRME as recently as Q4 2025.

Point72 Asset Management first reported a position in PRME in Q4 2024 and has held it in 3 quarters since. 188 funds tracked by Wall St. Rank hold PRME as of Q2 2026.

  • Point72 Asset Management held 533,553 shares of Prime Medicine worth $1.97M as of Q2 2026.
  • Prime Medicine was a new Point72 Asset Management position in Q2 2026.
  • Prime Medicine made up ﹤0.01% of Point72 Asset Management's portfolio in Q2 2026, its #2399 holding.
  • Point72 Asset Management first reported a position in Prime Medicine in Q4 2024 and has held it in 3 quarters since.
  • 188 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.